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Abstract objectives To identify indicators of quality use of medicines used in South-East Asian region.
methods A systematic review was conducted searching MEDLINE, Embase and The International
Network for Rational Use of Drugs (INRUD) and The World Health Organization (WHO) website.
Original studies or reports carried out in the South-East Asian region, explicitly using indicators to
measure quality use of medicines, and published between January 2000 and July 2011 were included.
results A total of 17 studies conducted in 7 of 11 countries in South-East Asia were included. WHO
indicators focusing on general medication use in health facilities were most widely used (10 studies).
Twelve studies used non-WHO indicators for measuring quality use of medicines in clinical areas
(geriatrics and obstetrics) or specific diseases, such as diarrhoea and pneumonia. In five studies, WHO
indicators were used along with non-WHO indicators. There was little information available about
validity, reliability and feasibility of the non-WHO indicators. The majority of indicators measured
process rather than structure or outcome. There were very few indicators addressing non-communicable
diseases.
conclusions A limited number of studies have been published explicitly using indicators of quality
use of medicines across South-East Asia. Importantly, existing indicators need to be complemented with
valid, reliable and feasible indicators related to non-communicable diseases, particularly those with a
high financial burden to meet the current medical challenges in the region.
keywords quality indicator, South-East Asia
Introduction
WHO (2010) estimated that more than half of all
medicines over the world were prescribed, dispensed or
sold inappropriately. Examples of irrational use of medi-
cines include use of too many medicines per patient (Hajjar
et al. 2007), inappropriate use of antimicrobials (Werner
et al. 2011) and failure to prescribe in accordance with
clinical guidelines (Ko et al. 2010). Over three decades ago,
the WHO in collaboration with the International Network
for Rational Use of Drugs (INRUD) developed a set of
indicators measuring quality use of medicines and
prescribing behaviour in health facilities (Hogerzeil et al.
1993; WHO 1993). These indicators are widely accepted
as an objective standard method to assess rational use of
medicines and have been used in over 30 countries, mainly
in the developing world (Laing et al. 2001; WHO 2004,
2009). Another set of WHO indicators addresses the
pharmaceutical situation of countries including rational
medicine use (WHO 2007b). Finally, more recently, WHO
has published a set of indicators for the use of medicines at
household level (WHO 2007a, 2011). Apart from the
widely used WHO indicators, measures of quality use of
medicines for specific diseases like asthma or diabetes have
been developed and applied in developed countries
(Martirosyan et al. 2010; To et al. 2010). Indicators are a
tool for policy-makers and healthcare managers to assess
and monitor the extent of rational medicine use, to
compare differences across facilities, districts or regions, to
analyse changes over time and to evaluate interventions
(Hogerzeil 1995; Quick et al. 1997; Laing et al. 2001;
Majeed et al. 2007).
South-East Asia is a region consisting of eleven countries –
Brunei, Singapore, Malaysia, Thailand, the Philippines,
Indonesia, Vietnam, Laos, Cambodia, Myanmar and East
Timor (PubMed definition). These countries have a com-
mon history, geography and position as a major crossroad
of trade and the movement of goods and services. Recently,
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a set of papers discussed health and relatedmatters in South-
East Asian countries as an emerging focus for global health
(Acuin et al. 2011; Chongsuvivatwong et al. 2011; Coker
et al. 2011; Dans et al. 2011; Kanchanachitra et al. 2011).
The region is dealing with the challenge of an increase in
non-communicable diseases associated with population
ageing. The health systems are a mix of traditional medical
practices and the use of new medical technologies and
pharmaceutical products, presenting problems in terms of
safety and quality. In addition, there is a rising demand for
high-quality health care because of increasing educational
levels and wealth as well as a growing consciousness of
human rights in societies with a developing democratic
environment. Although this series of papers addressed some
aspects of quality of health care and challenges related to
health insurance coverage, it did not address the quality use
of medicines or explicit methods to measure quality, neither
could we identify any other reviews on this topic. It remains
unknown whether existing indicators are suitable for the
current medical challenges. In this systematic review, we
aimed to identify studies explicitly using indicators of
quality use of medicines in the South-East Asian region
answering the following three research questions: (i) which
indicators have been used; (ii) what is known about the
validity, reliability and feasibility of the existing indicators;




A systematic literature review was conducted according to
the PRISMA instructions (Moher et al. 2009), using
PubMed (MEDLINE) and Embase databases with relevant
keywords: ‘quality indicators, health care’, ‘quality indi-
cator(s)’, ‘safety indicator(s)’, ‘indicator(s)’, ‘medication
errors’, ‘drug monitoring’, ‘adverse drug reaction reporting
systems’, ‘drug reporting system(s)’, ‘medical audit’,
‘quality assurance, health care’, ‘rational use’, ‘pharma-
ceutical preparations’, ‘medication’, ‘drug(s)’, ‘pharma-
ceutical sector’, ‘asia, southeastern’, ‘southeastern asia’,
‘southeast asia’, and individual country names as MeSH
terms and free-text words or combinations. We also
performed searches in INRUD bibliography (The Interna-
tional Network for Rational Use of Drugs: http://www.
inrud.org) and in the WHO (http://www.who.int) website
with the keyword ‘indicator(s)’. The searches were
restricted by published date between January 2000 and
July 2011, but not for languages.
Duplicated studies were eliminated. All remaining titles
and abstracts were independently screened and selected by
two authors (H.T.N and K.T). Disagreements were
resolved through discussion. Studies deemed relevant at the
first screening were retrieved in full-text format and
screened for further eligibility. Related articles and the
reference lists of reviewed articles were searched for
additional studies.
Inclusion criteria
We included original studies or reports that (i) were carried
out in South-East Asian region, (ii) explicitly used indicators
to measure quality use of medicines including prescribing,
dispensing and utilisation of medicines, adopted from
official sources ⁄ sets (e.g. WHO documents) or clearly
defined indicators (namely unambiguous descriptions and
clear definitions of variables to be measured, explicit
definition of the population to be included and the setting to
which they apply) (Hearnshaw et al. 2001; Campbell et al.
2003; Hepler & Segal 2003) and (iii) were published
between January 2000 and July 2011.
Exclusion criteria
We excluded studies that (i) used exclusively other methods
to describe ⁄measure rational use of medicines rather than
using indicators and (ii) did not provide sufficient details in
methods and results sections, thus failing to answer
research questions.
Data abstraction
The following information was extracted: first author,
publication year, country, design, study level (for example:
national, provincial or hospital), setting and objective of
study, number and description of indicators used. For
studies including multiple indicators, we only included
indicators addressing quality use of medicine and excluded
those relating to other aspects of care (for instance, access
to or quality of medicines). The first author extracted the
data and the last one checked this.
Data analysis
For each indicator of quality use of medicines, several
parameters were determined. To assess the original source
of the indicator, we checked whether indicators were
developed by WHO or not. The latter were named
non-WHO indicators. Similar indicators were grouped
together. We classified indicators according to the dimen-
sion of quality of care as structure (defined as the capacity
to provide high quality of care), process (referred to the
actions of healthcare providers, such as prescribing,
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dispensing, etc.) or outcome (including recovery, restora-
tion of functionality, knowledge about therapy and
survival of patients) indicators as described by Donabedian
(Donabedian 2005), irrespective of the category defined in
the original source, from which they were selected.
WHO indicators were developed by appropriate meth-
ods, well tested in many countries and applied in various
studies in a standard way: the face and content validity,
reliability and feasibility of those indicators have been
proven (WHO 1993, 2006a, 2007a, 2009, Brudon et al.
1999). All other indicators were evaluated on the infor-
mation provided in the studies and additional documents
cited in the original papers as follows (Martirosyan et al.
2010):
• Content validity: indicators were based on the literature
review or evidence-based clinical guidelines.
• Face validity: indicators were assessed and accepted by a
group of experts or professionals in the field.
• Feasibility: feasibility of calculation of indicators was
demonstrated or defended in the view of available data.
• Reliability: indicators yield the same outcome when
measured by different persons at different times.
The main results of most commonly used indicators
Results of commonly used indicators in the reviewed
articles were extracted and aggregated if there were at least
three results from different countries. We included the
results of both WHO and non-WHO indicators if their
contents were comparable and presented aggregated data
as a range for each indicator.
Results
In total, 696 potentially relevant articles were identified
(PubMed: 376, Embase: 308, INRUD: 9 and WHO: 3). Of
those, 19 original studies met the inclusion criteria and
were included in our analysis. Three papers (Stenson et al.
2001a,b; Syhakhang et al. 2001) were from a serial
publication relating to the same PhD research project and
are referred to as one study by (Syhakhang 2002). No
relevant studies were identified from searching the related
articles and the reference lists of included studies. As a
result, 17 different studies were included for review.
The greatest number of studies was carried out in Laos
(five studies). Others were conducted in Singapore (three
studies), Cambodia (two studies), Thailand (two studies),
Philippines (two studies), Vietnam (two studies) and
Malaysia (one study). The studies were performed at
different levels: national (12 studies), regional (one study),
provincial (three studies) and hospital (one study) using
two major designs: to describe the situation of medication
use (10 studies) or to assess practice improvement ⁄ impact
of a certain intervention (seven studies) (Table 1).
Four studies used indicators to assess the pharmaceutical
sector: one measured financial access to essential medicines
including only one indicator relating to medication dis-
pensing (Saleh & Ibrahim 2005), while the other three
investigated also geographical access to essential medi-
cines, quality and rational use of medicine (Falkenberg
et al. 2000; Paphassarang et al. 2002; Batangan & Juban
2009a). Another four studies described overall medicine
use patterns comprising prescribing and dispensing prac-
tices or assessed the impact of an intervention on these
issues in various health facilities (health centres, hospitals
and pharmacies) (Chareonkul et al. 2002; Syhakhang
2002; Keohavong et al. 2006; Vang et al. 2006). Indicators
were applied in different clinical areas including geriatrics
and obstetrics as well as in specific diseases comprising
malaria, diarrhoea, pneumonia, psychosis, asthma, tuber-
culosis and diabetes in seven studies (Wahlstrom et al.
2003; Mamun et al. 2004; Chong et al. 2006, 2008;
Uchiyama et al. 2006; Liabsuetrakul et al. 2008; Kancha-
naphibool et al. 2009). One study evaluated the effective-
ness of an intervention in the utilisation of antibiotics
(Chalker 2001). Finally, one study described medication
use in households (Batangan & Juban 2009b) (Table 1).
WHO indicators
About half of the studies (10 studies, 59%) applied
indicators developed by the WHO with some studies
slightly modifying the indicators to fit the specific contexts
(Paphassarang et al. 2002; Syhakhang 2002; Vang et al.
2006; Batangan & Juban 2009a,b). For instance, Vang
et al. (2006) had scored indicators based on a 10-point
scale instead of using percentages or absolute numbers as
recommended by WHO. Prescribing and dispensing prac-
tices at facility level were assessed by using indicators of
quality use of medicines in health facilities (WHO 1993).
Those indicators were developed a long time ago, updated
various times and incorporated into the package for
assessing country pharmaceutical situation (WHO 2007b).
The use of medicines at home was measured by using
another set of WHO indicators for the household survey
(WHO 2007a). Most of the studies using WHO indicators
measured processes, only few focused on structures and
outcomes (Appendix 1).
Non-WHO indicators
Twelve studies used non-WHO indicators, which were
developed either by a national organisation or by the
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authors themselves. In five studies, non-WHO indicators
were used along with the WHO indicators (Chalker 2001;
Chareonkul et al. 2002; Paphassarang et al. 2002; Syhak-
hang 2002; Vang et al. 2006). Those indicators were
categorised into four groups: (i) rational medicine use in
general, (ii) quality of pharmacy practice (Good Pharmacy
Practice (GPP) indicators), (iii) rational medicine use in
specific clinical areas or diseases (Clinical area ⁄disease-
oriented indicators) and (iv) other aspects involving med-
ication use (Appendix 2).
Few non-WHO indicators sets were judged to be face
and content valid and reliable (Table 2). These indicators
were developed based on experts’ consensus and related
to available literature or standard treatment guidelines
and tested within local contexts. For instance, Good
Pharmacy Practice (GPP) indicators were developed by
Lao Food and Drug Department and tested for reliability
in pharmacies (Paphassarang et al. 2002; Syhakhang
2002); or indicators assessing adherence to standard
treatment guidelines of malaria, diarrhoea and pneumo-
nia were developed in the Lao National Drug Policy
(NDP) implementation programme and tested by the
Department of Curative Medicine in a hospital
(Wahlstrom et al. 2003). Most studies described indica-
tors that were based on existing literature and ⁄or clinical
guidelines, and these were judged to have content
validity. Four studies did not provide any data or
reported ambiguous messages on the process of develop-
ing and testing the indicators (Chalker 2001; Chareonkul
et al. 2002; Paphassarang et al. 2002; Chong et al. 2008),
so content and face validity could not be determined. All
of the non-WHO indicators reported results and were
therefore assumed to be feasible within the context of
the specific study, except for the indicators assessing
adherence to Lao standard treatment guidelines of
malaria, diarrhoea and pneumonia as they were used in
two distinct studies (Wahlstrom et al. 2003; Vang et al.
2006). However, the feasibility of all of these indicators
on a larger scale was not tested. The exception was the
Lao GPP indicator study which confirmed the feasibility
of the indicators as they were regularly used for inspec-
tion of pharmacies in Laos (Paphassarang et al. 2002;
Syhakhang 2002) (Table 2). Most of the non-WHO
indicators identified were process, followed by structure
and outcome indicators (Appendix 2).
Summary results of most commonly used indicators of
quality use of medicines
Only a limited number of studies used indicators that
allow comparison of results across countries. Among the
identified indicators, the most prominent ones were
Table 2 Evaluation of non-WHO indicators of quality use of medicines*
Indicators
Evaluation
Content validity Face validity Feasibility Reliability
1. Rational medicine use in general
Antibiotic use (Chalker 2001) ) ) ± )
Medicine use in hospital (Vang et al. 2006) ) + ± )
Patient care and facility (Chareonkul et al. 2002) ) ) ± )
2. Good pharmacy practice (GPP) indicators (Syhakhang 2002;
Paphassarang et al. 2002)
Facility specific indicators
Dispensing indicators
+ + + +
3. Clinical area ⁄ disease-oriented indicators
Geriatrics (Mamun et al. 2004) + ) ± )
Obstetrics (Liabsuetrakul et al. 2008) + ) ± )
Malaria, diarrhea and pneumonia (Chareonkul et al. 2002) + ) ± )
(Vang et al. 2006; Wahlstrom et al. 2003) + + ± +
Asthma (Chong et al. 2008) ) ) ± )
Diabetic (Kanchanaphibool et al. 2009) + ) ± )
Psychosis (Chong et al. 2006) + ) ± )
Tuberculosis (TB) (Uchiyama et al. 2006) + ) ± )
4. Others
National Drug Policy (NDP) (Paphassarang et al. 2002) ) ) ± )
Drug and Therapeutics Committee (DTC) (Vang et al. 2006) + ) ± )
(+), Positive information; ()), No ⁄ ambiguous information; (±), Limited information.
*List of non-WHO indicators used in the included studies is provided in Appendix 2.
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indicators addressing prescribing and dispensing ⁄patient
care practices of healthcare providers (Table 3).
Rational medicine use in general was measured in seven
studies. The overall results showed wide variation for all
indicators involved, often with about twofold differences.
For example, the number of medicines per prescription
ranged from 1.4 to 3.8. The percentage of medicines
prescribed from the essential medicine list was encouraging
in some health facilities with a percentage of nearly 100.0,
but still poor in other studied sites (56.0%). The most
extreme difference was the percentage of encountering an
injection, which was 1.3% in Laos (Paphassarang et al.
2002) and 32.0% in Vietnam (Falkenberg et al. 2000).
Appropriateness of medicine use for treatment of a
specific disease, that is, diarrhoea, in children under 5-year
old was addressed in five studies. The findings varied
between 60.0 and 100.0%, 22.0–81.3% and 0.0–30.0% of
patients with simple diarrhoea prescribed oral rehydration
salts ⁄ solutions (ORS), antibiotics and antidiarrhoea ⁄
antispasmodic drugs, respectively.
Quality of medication dispensing or patient care was
assessed in four studies. Most patients (55.0–80.0%) knew
how to take medicines in the majority of cases (84.8–
100.0%) studied. However, labelling medicines broadly
varied from not being labelled at all to almost adequate.
Discussion
A total of 17 studies conducted in seven countries in South-
East Asia using indicators of quality use of medicines were
included in this review. WHO indicators mainly focusing
on general medication use in health facilities were most
frequently used. New indicators for measuring quality use
of medicines in specific clinical areas ⁄diseases have been
developed with little information on their validity, reli-
ability and feasibility. The majority of indicators identified
measured process, followed by structure and outcome.
We did not find studies from Brunei, Indonesia, Myan-
mar and East Timor. Furthermore, with the exception of
Laos, only few studies were performed in each country.
One of the reasons may be that these are mainly developing
countries (except for Singapore) where electronic medical
records and insurance data are often absent and monitor-
ing of medicine use is not undertaken (Holloway & Van
Table 3 Results of most commonly used indicators in Southeast Asia
Indicators Results*
General prescribing indicators
Average number of medicines per encounter ⁄ prescription ⁄ patient (Syhakhang 2002; Paphassarang
et al. 2002; Falkenberg et al. 2000; Batangan & Juban 2009a; Chareonkul et al. 2002; Keohavong et al. 2006)
1.4–3.8
Percentage of medicines prescribed by generic name (Syhakhang 2002; Batangan & Juban 2009a;
Chareonkul et al. 2002; Keohavong et al. 2006)
35.0–99.8
Percentage of encounters ⁄ patients with an antibiotic prescribed (Syhakhang 2002; Paphassarang et al. 2002;
Batangan & Juban 2009a; Chareonkul et al. 2002; Keohavong et al. 2006; Chalker 2001)
13.1–66.0
Percentage ⁄ number of encounters ⁄ patients with an injection prescribed (Syhakhang 2002; Paphassarang
et al. 2002; Falkenberg et al. 2000; Batangan & Juban 2009a; Chareonkul et al. 2002; Keohavong et al. 2006)
1.3–32.0
Percentage of medicines prescribed from essential medicines list or formulary (Syhakhang 2002;
Paphassarang et al. 2002; Batangan & Juban 2009a; Chareonkul et al. 2002; Keohavong et al. 2006)
56.0–99.7
Prescribing indicators for treatment simple diarrhea in children under age 5
Percentage of patients prescribed Oral Rehydration Salts ⁄ Solutions (ORS) (Paphassarang et al. 2002;
Batangan & Juban 2009a; Chareonkul et al. 2002; Keohavong et al. 2006)
60.0–100.0
Percentage of patients prescribed antibiotics (Paphassarang et al. 2002; Batangan & Juban 2009a;
Chareonkul et al. 2002; Keohavong et al. 2006)
22.0–81.3
Percentage of patients prescribed anti-diarrheal ⁄ antispasmodic drugs (Paphassarang et al. 2002;
Falkenberg et al. 2000; Batangan & Juban 2009a; Keohavong et al. 2006)
0.0–30.0
Dispensing ⁄ patient care indicators
Percentage of medicines dispensed ⁄ received ⁄ administered (Saleh & Ibrahim 2005; Batangan &
Juban 2009a; Chareonkul et al. 2002; Keohavong et al. 2006)
84.8–100.0
Percentage of medicines adequately labeled (Batangan & Juban 2009a; Chareonkul et al. 2002;
Keohavong et al. 2006)
0.0–97.1
Patients’ knowledge of correct dosage ⁄ how to take medicines (Batangan & Juban 2009a; Chareonkul
et al. 2002; Keohavong et al. 2006)
55.0–80.0
*Due to small number of studies, only ranges are presented.
Included the results of non-WHO indicators whose contents were comparable to those of WHO indicators.
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Dijk 2011). Also, scientific journals may not be interested
in publishing studies on routine monitoring of drug
utilisation. Based on the limited data, quality use of
medicines in South-East Asia was suboptimal and varied
greatly. Some of the comparisons are restricted because
target values for indicators are not available or depend on
local practices. In view of the sparse data, it was not feasible
to conduct statistical analysis. We found that between 1.4
and 3.8 medicines were prescribed per encounter, which is
only partly in line with the range of 2.0–2.7 identified in a
recent large study (WHO 2009). A value of two was
suggested to be adequate (Chareonkul et al. 2002; Batangan
& Juban 2009a), but five studies reported a value of more
than two (Falkenberg et al. 2000; Chareonkul et al. 2002;
Paphassarang et al. 2002; Syhakhang 2002; Keohavong
et al. 2006). The percentage of prescriptions with an
antibiotic or with an injection also varied widely; a
threshold of not more than 30% has been recommended for
injection (WHO 1993). Differences could be because of
disease patterns, health policies (e.g. effort to improve
prescribing pattern) and culture. For example, the rate of
injections per prescription in the study by Falkenberg was
probably high, because many patients, especially in moun-
tainous areas, expected injections of vitamins (Falkenberg
et al. 2000). Medicine use for the treatment of a disease (in
children under 5-year old) was also suboptimal: not all
patients with simple diarrhoea were prescribed ORS, but
were given antibiotics and antidiarrhoea ⁄ antispasmodic
drugs. These results were in line with the findings of a recent
study at global level (WHO2009). Themost frequently used
indicators were the ones developed by the WHO, especially
the core set of indicators (WHO 1993). This is a well-
accepted, highly standardised simple tool for fast and
reliably assessing general medicine use, recommended for
application in any medicine use study. The indicators for
common specific diseases (including acute diarrhoea, acute
respiratory infection and malaria) described in the annex
(WHO 1993) were not used. Studies addressing the latter
used indicators from other sources or developed their own
(Falkenberg et al. 2000; Chareonkul et al. 2002; Paph-
assarang et al. 2002; Keohavong et al. 2006; Batangan &
Juban 2009a). Three studies used WHO indicators for
monitoring national drug policies (NDP) including indica-
tors for rational use of medicines (Falkenberg et al. 2000;
Paphassarang et al. 2002; Saleh & Ibrahim 2005). The two
sets of indicators mentioned previously were further devel-
oped and incorporated into theWHO package of indicators
for assessing, monitoring and evaluating country pharma-
ceutical situations (WHO 2006b), which were applied in
two studies (Keohavong et al. 2006; Batangan & Juban
2009a). Only one study used WHO indicators for the
household survey to measure quality use of medicines at
home (Batangan & Juban 2009b), possibly because this set
is rather new (WHO 2007a, 2011).
More studies are needed using WHO indicators to assess
quality use of medicines in the region to fill the gap in
knowledge as highlighted previously. However, current
WHO indicators do not address the recent changes of the
health situation in the region with increasing chronic
diseases and ageing population. They should be comple-
mented with indicators related to non-communicable
diseases, particularly those with a high financial burden.
Encouragingly, there are some studies measuring quality
use of medicines in specific medical fields (geriatrics and
obstetrics) or in specific diseases (psychosis, asthma,
tuberculosis, diabetes). However, they were mostly used in
the context of a single study with insufficient information
to assess their validity and reliability (Mamun et al. 2004;
Chong et al. 2006, 2008; Uchiyama et al. 2006; Lia-
bsuetrakul et al. 2008; Kanchanaphibool et al. 2009).
Indicators should be developed using appropriate methods,
for example, RAND (Campbell et al. 2003). Standard sets
of valid and reliable indicators should be used in studies
evaluating medication use to generate consistent data to
facilitate the comparison across countries or regions.
Indicators can then serve as a tool to revise medicine
policies and to develop strategies for enhancing quality use
of medicines at both national and regional levels.
Most indicators were process indicators rather than
structure or outcome indicators. This is not surprising as
most indicators assessed rational use of medicines, which is
by definition a process indicator (Mainz 2003; Donabedian
2005). In general, structures are often readily formulated
and easily measured, but are not always associated with
better processes that yield the desired health outcomes.
There is more evidence that process indicators are linked
with outcome, but even this is not true for all situations
(Sidorenkov et al. 2011). Furthermore, the process of care
is in the control of healthcare providers and reflects their
quality of care provision. Process indicators are therefore
well suited to identify areas of possible change and to
evaluate interventions. Outcomes are not always direct
measures of the quality of health care provided and are
likely to be influenced by patient-related factors (e.g.
severity of the disease, patient age) and may take a very
long time to occur (e.g. mortality or target blood pressure
in hypertension) (Mainz 2003; Donabedian 2005).
Strengths and limitations of the review
There is no defined keyword for ‘indicator(s) of quality use
of medicines’. We combined all potentially relevant MeSH
terms and free-text terms. We found no additional
studies searching the related articles or screening the lists of
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references of included studies, indicating we have included
the studies that met our inclusion criteria, in correspon-
dence with the aim of the study. Secondly, we excluded
studies on rational use of medicines in which the authors
did not use the concept of indicator explicitly, for example
Chuc et al. (2001) or Ayuthya et al. (2003). A complete
overview of rational use of medicines in South-East Asia
was outside the scope of the present study. Thirdly, there
are inconsistencies in the definition of South-East Asia in
the literature. The WHO has divided this area into two
subregions, South-East Asia consisting of Indonesia,
Myanmar, Thailand and East Timor and Western Pacific
encompassing Brunei, Cambodia, Laos, Malaysia, Philip-
pines, Singapore and Vietnam. Others included ten
countries as members of ASEAN organisation, which
excludes East Timor (Chongsuvivatwong et al. 2011). We
considered South-East Asia as a region covering eleven
countries, ten ASEAN members and East Timor, using the
PubMed categorisation. Lastly, we did not search for
unpublished papers or grey literature because of feasibility
and resources. In an attempt to seek relevant locally
published studies, one of the authors (H.T.N, Vietnamese)
carried out a manual search of the relevant pharmaceutical
and medical journals published in Vietnamese, but no
studies were identified.
In conclusion, a limited number of studies have been
carried out using indicators of quality use of medicines
across South-East Asia. WHO indicators focusing on
general medication use in health facilities were mainly
used. Non-WHO indicators often lacked information
on validity, reliability and feasibility. As far as results
could be compared between studies, suboptimal quality
use of medicine is indicated. Most importantly, exist-
ing indicators need to be complemented with valid,
reliable and feasible indicators related to non-
communicable diseases, particularly those with a high
financial burden to meet the current medical challenges
in the region.
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Appendix 1 List of WHO indicators used in reviewed articles
Type of indicators St Pr Ot References
Indicators of quality use of medicines at
health facility level
2 17 1
Prescribing indicators in general
Average number of medicines per
encounter ⁄ prescription ⁄ patient
X (Keohavong et al. 2006;
Paphassarang et al. 2002;
Syhakhang 2002; Vang et al. 2006;
Chareonkul et al. 2002; Chalker 2001;
Falkenberg et al. 2000; Saleh &
Ibrahim 2005; Batangan & Juban 2009a)
Percentage of medicines prescribed by
generic name
X
Percentage of encounters ⁄ patients with an
antibiotic prescribed
X
Percentage ⁄ number of encounters ⁄ patients
with an injection prescribed
X
Percentage of medicines prescribed from
essential medicines list or formulary
X
Number of medicines from the national
essential medicines list, out of the 50
best-selling medicines in the private sector
X
Percentage of prescription medicines
bought with no prescription
X
Prescribing indicators for specific diseases
Simple diarrhoea in children under age 5
Percentage of patients prescribed oral
rehydration salts ⁄ solutions (ORS)
X
Percentage of patients prescribed
antibiotics
X
Percentage of patients prescribed
anti-diarrheal ⁄ antispasmodic drugs
X
Mid ⁄moderate pneumonia in children under age 5
Percentage of patients prescribed first-line
antibiotics
X
Percentage of patients prescribed more
than one antibiotic
X
Non-pneumonia (flu) in patients of any age
Percentage of patients prescribed
antibiotics
X
Dispensing ⁄ patient care indicators
Average consultation time X
Average dispensing time X
Percentage of medicines
dispensed ⁄ received ⁄ administered
X
Percentage of medicines adequately
labelled
X
Tropical Medicine and International Health volume 17 no 12 pp 1552–1566 december 2012
H. T. Nguyen et al. Indicators of quality use of medicines
ª 2012 Blackwell Publishing Ltd 1563
Appendix 1 (Continued)
Type of indicators St Pr Ot References




Availability of copy of essential medicines list
or formulary
X
Availability of standard treatment guidelines
at public health facilities
X
Indicators of quality use of medicines at
household level
0 0 1
Rational use of medicines at home* X (Batangan & Juban 2009b)
St, structure; Pr, process; Ot, outcome; The classification of structure, process and outcome indicators based on the aspect of care as
described by Donabedian.
*It was not reasonable to list individual indicators; Full lists of indicators used in original articles were not shown; only indicators relating
to quality use of medicines were reported.
Appendix 2 List of non-WHO indicators used in reviewed articles
Type of indicators St Pr Ot References
1. Rational medicine use in general 1 6 1
Antibiotic use
Antibiotic dose (% of patients receiving an
adequate antibiotic dose)
X (Chalker 2001)
Medicine use in hospital
Medicine in hospital X (Vang et al. 2006)
Clear writing X
Traditional medicine X
Rational use of antibiotic X
Rational use of injection X
Patient care and facility
Percentage patients confirmation of medicine
instruction
X (Chareonkul et al. 2002)
Use pictogram (plastic bag) X
2. Good pharmacy practice (GPP) indicators 2 3 0
Facility specific indicators
Order in the pharmacy X (Paphassarang et al. 2002;
Syhakhang 2002)Essential materials available in the pharmacy X
Dispensing indicators
Labelling X
Mixing of medicines X
Information ⁄ percentage of informed
customers
X
3. Clinical area ⁄ disease-oriented indicators 0 23 1
Geriatrics
Polypharmacy (an order of ‡ 5 medications per
resident)
X (Mamun et al. 2004)
Inappropriate medication use (based on




Seizure treatment and prophylaxis with
magnesium sulphate
X (Liabsuetrakul et al. 2008)
Tropical Medicine and International Health volume 17 no 12 pp 1552–1566 december 2012
H. T. Nguyen et al. Indicators of quality use of medicines
1564 ª 2012 Blackwell Publishing Ltd
Appendix 2 (Continued)
Type of indicators St Pr Ot References
Antihypertensive treatment was given when blood
pressure ‡160 ⁄ 110 mm Hg
X
Respiratory rate and tendon reflexes monitored in
women treated with magnesium sulphate
X
Intravenous access and hydration was achieved in
women with obstructed labor
X
Antibiotic prophylaxis was given during caesarean
delivery
X
Intravenous access achieved and crystalloids and ⁄ or
colloids should be infused in women with
postpartum haemorrhage
X
Administration of uterotonics was recorded X
Malaria, diarrhoea and pneumonia
Indicator for in ⁄ out patient treatment of malaria in
adherence to standard treatment guideline (STG)
X (Vang et al. 2006;
Chareonkul et al. 2002;
Wahlstrom et al. 2003)Indicator for in ⁄ out patient treatment of pneumonia
in adherence to STG
X
Indicator for in ⁄ out patient treatment of diarrhoea in
adherence to STG
X
Percentage of children <5 with ARI given antibiotics X
Asthma
Preventer (corticosteroid inhalers) - reliever
(short-acting beta agonist inhalers) prescription ratio
in asthma treatment
X (Chong et al. 2008)
Diabetic
Antiplatelet therapy to prevent cardiovascular disease
in diabetic patients over age 40 year old
X (Kanchanaphibool et al.
2009)
Psychosis
Patients hospitalised for an acute episode of psychosis
and prescribed an antipsychotic medication on
discharge
X (Chong et al. 2006)
Patients treated with antipsychotic medication for at
least three months and received a medication
adjustment following persistent psychotic symptoms
or antipsychotic-related side effects
X
Patients discontinued from antipsychotic medications
and have a documented plan for recognizing and
responding to signs of relapse
X
Patients who had at least four medication or
psychotherapy visits with a psychiatrist within a
year from first visit
X
Patients treated with antipsychotic medication and
evaluated for medication side effect within three
months of prescription
X
Patients who had either one inpatient admission or
two outpatient visits for psychosis within a
12-month period and received education about their
prescribed medications and side effects
X
Patients prescribed oral antipsychotic drugs, reported




Percentage of smear-positive TB patients who
received correct TB drugs in correct dosages
X (Uchiyama et al. 2006)
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Appendix 2 (Continued)
Type of indicators St Pr Ot References
Percentage of new smear-positive TB out-patients
with correct knowledge of TB treatment
X
4. Others 2 0 0
National Drug Policy (NDP)
The use of standard treatment guidelines (STGs) X (Vang et al. 2006;
Paphassarang et al. 2002)Drug and Therapeutics Committee (DTC)
DTC drug information X
St, structure; Pr, process; Ot, outcome; The classification of structure, process and outcome indicators based on the aspect of care as
described by Donabedian.
Full lists of indicators used in original articles were not shown; only indicators relating to quality use of medicines were reported.
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